OpenLB
Open Library of Bioscience
Advanced Search

Journal

Publication Year

1 year 3 years 5 years 10 years
2021 - 2032
202120222023
202420252026
202720282029
203020312032
2021 - 2032
202120222023
202420252026
202720282029
203020312032

Publication Type

Associated Data

Found 3,307 results

Filters: booster antigen

Booster and higher antigen doses of inactivated influenza vaccine in HIV-infected patients.
Jessica A Johnston, Lindsey B Tincher, Denise K Lowe
Ann Pharmacother. Dec, 2013.47(12):1712-6 Print-Electronic
Source:PubMed
PMID: 24259616 doi:10.1177/1060028013507901
A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix™) is immunogenic and well tolerated in adults.
Robert Booy, Olivier Van der Meeren, Su-Peing Ng, Froilan Celzo, Gunasekaran Ramakrishnan, Jeanne-Marie Jacquet
Vaccine. Dec 10, 2010.29(1):45-50 Print-Electronic
Source:PubMed
PMID: 20974302 doi:10.1016/j.vaccine.2010.10.025
Booster vaccination of toddlers with reduced antigen content diphtheria -- tetanus -- acellular pertussis vaccine.
Terry Nolan, Tilman A Ruff, Stephen B Lambert, Jim Buttery, Kerry-Ann O'Grady, Catherine Streeton, Bernard Hoet, Hans L Bock
Vaccine. Apr 21, 2009.27(18):2410-3 Print-Electronic
Source:PubMed
PMID: 19368781 doi:10.1016/j.vaccine.2009.02.065
IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content.
Lotte H Hendrikx, Guy A M Berbers, Reinier H Veenhoven, Elisabeth A M Sanders, Anne-Marie Buisman
Vaccine. Nov 05, 2009.27(47):6530-6 Print-Electronic
Source:PubMed
PMID: 19729085 doi:10.1016/j.vaccine.2009.08.052
Antigen-induced bronchial anaphylaxis in actively sensitized guinea pigs. The effect of booster injection and cyclophosphamide treatment.
P Andersson
Int Arch Allergy Appl Immunol. 1981.64(3):249-58 Print
Source:PubMed
PMID: 6163733 doi:10.1159/000232701
The safety and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis (dTpa) booster vaccine in healthy Vietnamese children.
Dang Duc Anh, Girish Jayadeva, Sherine Kuriyakose, Htay Htay Han
Vaccine. 08 17, 2016.34(37):4360-3 Print-Electronic
Source:PubMed
PMID: 27435387 doi:10.1016/j.vaccine.2016.07.005
Reduced-antigen, combined diphtheria, tetanus, and acellular pertussis vaccine, adsorbed (boostrix(®)): a guide to its use as a single-dose booster immunization against pertussis.
Lesley J Scott, Paul L McCormack
BioDrugs. Feb, 2013.27(1):75-81 Print
Source:PubMed
PMID: 23329401 doi:10.1007/s40259-012-0009-y
Acute and long-term effects of booster immunisation on frequencies of antigen-specific memory B-lymphocytes.
R Nanan, D Heinrich, M Frosch, H W Kreth
Vaccine. Nov 12, 2001.20(3-4):498-504 Print
Source:PubMed
PMID: 11672915 doi:10.1016/s0264-410x(01)00328-0
Reactogenicity and immunogenicity of reduced antigen content diphtheria-tetanus-acellular pertussis vaccines as a booster in 4-7-year-old children primed with diphtheria-tetanus-whole cell pertussis vaccine before 2 years of age.
R Dagan, K Igbaria, L Piglansky, F Van Brusteghem, V Melot, A Kaufhold
Vaccine. Jun 04, 1999.17(20-21):2620-7 Print
Source:PubMed
PMID: 10418911 doi:10.1016/s0264-410x(99)00065-1
Antigen content of inactivated poliovirus vaccine for use in a one- or two-dose regimen.
J Salk, P Stoeckel, A L van Wezel, K Lapinleimu, G van Steenis
Ann Clin Res. Dec, 1982.14(5-6):204-12 Print
Source:PubMed
PMID: 7171229 doi:
0